| We have 29 articles this week. #PaciraBioSciences to Acquire #FlexionTherapeutics Further Expanding Leadership Position in Non-Opioid Pain Management. #SupernusPharmaceuticals to Acquire #AdamasPharmaceuticals Strengthening its CNS Product Portfolio. #Neumora Explodes onto Neuro Scene with $500 Million and #Amgen Alliance. #GenesisBiotechnologyGroup Acquires #BioBlocks to Grow the Preclinical Chemistry Services Portfolio of Genesis Drug Discovery & Development (GD3). #PAVmed Acquires EsophaCap Manufacturer #CapNostics LLC. #Tekni-Plex Acquires #JohnsonPlasticGroup, Expands Medical Device Footprint. #ALXOncology Strengthens Immuno-Oncology Pipeline with Acquisition of #ScalmiBio. #SyneosHealth Acquires #RxDataScienceAcquisition Delivers AI and Data Engineering Expertise, Enterprise Analytics and Technology-Enabled Solutions to Accelerate Customer Performance. #BostonScientific Announces Agreement to Acquire #Baylis Medical Company Inc.. #FortressBiotech Announces Closing of Acquisition of #CaelumBiosciences by #AstraZeneca. |
| Editor's Choice |
|
1.
|
SPACs Offer Efficiency and Flexibility for Biopharma Startups. Will the Trend Last? |
|
2.
|
Life Sciences BPO Market to See Booming Growth, Forecast 2028 | Accenture,, Boehringer Ingelheim GmbH, Charles River Laboratories International, |
|
3.
|
Strong Pipeline of Drugs for Treatment Of Psychotic Disorders Anticipated To Drive The Market Through 2028 |
|
4.
|
Stakeholder Collaborations Essential to Making Things Happen in Rare Disease Space |
|
5.
|
COVID-19 spurs on digital healthcare mergers and acquisitions, higher valuations |
| Top 10 M&A Transactions |
|
6.
|
Pacira BioSciences to Acquire Flexion Therapeutics Further Expanding Leadership Position in Non-Opioid Pain Management |
|
7.
|
Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio |
|
8.
|
Neumora Explodes onto Neuro Scene with $500 Million and Amgen Alliance |
|
9.
|
Genesis Biotechnology Group Acquires BioBlocks to Grow the Preclinical Chemistry Services Portfolio of Genesis Drug Discovery & Development (GD3) |
|
10.
|
PAVmed Acquires EsophaCap Manufacturer CapNostics LLC |
|
11.
|
Tekni-Plex Acquires Johnson Plastic Group, Expands Medical Device Footprint |
|
12.
|
ALX Oncology Strengthens Immuno-Oncology Pipeline with Acquisition of ScalmiBio |
|
13.
|
Syneos Health Acquires RxDataScienceAcquisition Delivers AI and Data Engineering Expertise, Enterprise Analytics and Technology-Enabled Solutions to Accelerate Customer Performance |
|
14.
|
Boston Scientific Announces Agreement to Acquire Baylis Medical Company Inc. |
|
15.
|
Fortress Biotech Announces Closing of Acquisition of Caelum Biosciences by AstraZeneca |
| Top 3 Venture Funding |
|
16.
|
Octave Bioscience Announces Strategic Investment from the Merck Global Health Innovation Fund to Transform Disease Measurement and Care for Patients with Neurodegenerative Diseases |
|
17.
|
Behavioral health coaching unicorn BetterUp lands $300M in Series E round |
|
18.
|
Lightship Raises $40M to Bring Decentralized Clinical Trials at Scale |
| Top 4 Partnerships Announcements |
|
19.
|
TRACON Pharmaceuticals and Eucure Biopharma, a Subsidiary of Biocytogen, Announce Partnership for Development of Clinical Stage CTLA-4 Antibody YH001 |
|
20.
|
Kiromic BioPharma Announces Strategic Collaboration with Gemelli Teaching Hospital to Accelerate the Analysis of Allogeneic CAR-T Clinical Trial Candidate Alexis ISO-1 in Solid Cancers |
|
21.
|
Mirati and Sanofi Unite on Trial for KRAS Inhibitor |
|
22.
|
Pfizer and Voyager Launch $630 Million Gene Therapy Technology Pact |
|
Read More Corporate Development and M&A Activity |
|
5760 Legacy Dr, B3-405,
+1 469-270-3311